MAP3K3 and cerebral cavernous malformation: Studies have identified a “gut–brain axis” in CCM mouse models, where gram‐negative bacteria in the gut can secrete lipopolysaccharides that activate the MEKK3 pathway through EC TLR4 receptors, exacerbating CCM lesions.126, 127